CytomX reports promising Phase 1 data for CX-2051 in advanced colorectal cancer, with planned Phase 2 study in 2026. CytomX Therapeutics announced positive interim results from its Phase 1 study of CX ...

CytomX Therapeutics, Inc. (CTMX) is gearing up to release its Q1 2024 earnings results post-market on May 8th of 2024. With this update on earnings, a good reason to keep an eye on this biotech is ...

- 28% confirmed response rate (5/18) per RECIST v1.1 in unselected patients across doses prioritized for expansion (7.2, 8.6 and 10 mg/kg Q3W)- - 3 of 7 evaluable patients (43%) with confirmed ...

To effectively track customer retention and ensure growth, customer experience (CX) leaders must have a clear view of customer retention as a basic statistic, as well as lifetime value (LTV). By ...

AI is transforming customer experience across the enterprise. CX excellence requires seamless coordination across operations. The workforce includes agentic AIs that augment human capabilities. Last ...

Modern CX depends less on where data lives and more on how signals, AI, and governance come together at decision time. For much of the past decade, customer data platforms (CDPs) were positioned as ...

According to McKinsey, 33% of companies are implementing GenAI solutions in one or more business areas. What about the other 67% of companies? Why aren’t they implementing GenAI solutions now? Several ...

CallMiner's annual CX Landscape Report reveals organizations are scaling AI implementation while still grappling with organizational challenges, such as analyzing data and acting on insights AI ...

Get a 3X greater YOY improvement in CSAT with AI-driven insights. Over the past few years, businesses of all sizes and across various industries have ramped up their investment in AI technology. This ...

Despite years of investment, most enterprises still can’t easily unify voice, chat, and customer relationship management (CRM) data to generate meaningful customer insights. Unifying this data is ...